4 Financial assets

	Subsidiaries		Associates and JVs		Other participating interests	Receivables	Total
	Share in equity	Loans	Share in equity	Loans	Other participating interests	Receivables	Total

Balance at 1 January 2018	9,409	-	140	-	-	91	9,640

Changes:
Share in profit	1,054	-	11	-	-	-	1,065
Charged to income statement	-	-	-	-	-	(33)	(33)
Dividend received	(198)	-	-	-	-	-	(198)
Capital payments	49	-	-	-	-	-	49
Net actuarial gains/(losses)	(66)	-	-	-	-	-	(66)
Change in Fair value reserve	15	-	-	-	1	-	16
Change in Hedging reserve	(38)	-	(2)	-	-	-	(40)
Exchange differences	138	-	-	-	-	-	138
Disposals	-	-	(144)	-	-	-	(144)
Others	44	-	(5)	-	36	(22)	53

Balance at 31 December 2018	10,407	-	-	-	37	36	10,480

Changes:
Share in profit	800	-	-	-	-	-	800
Charged to income statement	-	-	-	-	-	(9)	(9)
Dividend received	(877)	-	-	-	-	-	(877)
Capital payments	254	-	-	-	-	-	254
Net actuarial gains/(losses)	(16)	-	-	-	-	-	(16)
Change in Fair value reserve	(19)	-	-	-	(1)	-	(20)
Change in Hedging reserve	21	-	-	-	-	-	21
Exchange differences	129	-	-	-	-	-	129
Other	(13)	-	-	-	-	(2)	(15)

Balance at 31 December 2019	10,686	-	-	-	36	25	10,747

For movements in 'Associates and joint arrangements', see Note 10 to the 'Consolidated financial statements'.

Disposals in 2018 relate to the divestment of DSM's share in DSM Sinochem Pharmaceuticals.

2019Statements